Chan Xie Selected Research

Epidermal Growth Factor (EGF)

4/2009

Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chan Xie Research Topics

Disease

15	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2013
9	Hepatitis B 08/2023 - 04/2009
7	Chronic Hepatitis B 11/2023 - 09/2011
7	Acute-On-Chronic Liver Failure 08/2023 - 01/2016
6	Neoplasms (Cancer) 01/2023 - 01/2012
4	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2018
3	Fibrosis (Cirrhosis) 04/2022 - 09/2011
3	Carcinogenesis 07/2013 - 06/2011
2	Infections 11/2023 - 01/2019
2	End Stage Liver Disease 01/2022 - 09/2011
2	Liver Diseases (Liver Disease) 01/2019 - 11/2008
2	Liver Failure 03/2014 - 09/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Disease Progression 02/2022
1	Hepatic Encephalopathy 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 02/2021
1	Bone Diseases (Bone Disease) 02/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Hepatitis 01/2015

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
5	CateninsIBA 08/2021 - 01/2018
4	BilirubinIBA 08/2023 - 09/2011
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 02/2022
3	Alanine Transaminase (SGPT)IBA 08/2023 - 09/2011
3	Transcription Factor 7-Like 2 ProteinIBA 06/2023 - 11/2019
2	Hepatitis B e AntigensIBA 11/2023 - 02/2022
2	Urea (Carbamide)FDA LinkGeneric 08/2023 - 01/2022
2	NitrogenIBA 08/2023 - 01/2022
2	beta CateninIBA 06/2023 - 11/2019
2	InterferonsIBA 10/2022 - 02/2022
2	tenofovir alafenamideIBA 02/2022 - 01/2021
2	Galectin 3 (LGALS3)IBA 08/2021 - 02/2021
2	Therapeutic UsesIBA 01/2021 - 01/2012
2	Complement C2 (Complement Component 2)IBA 10/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Tenofovir (Viread)FDA Link 02/2022
1	FumaratesIBA 02/2022
1	entecavir FDA Link 02/2022
1	NucleotidesIBA 02/2022
1	CreatinineIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	LectinsIBA 02/2021
1	UbiquitinIBA 02/2021
1	Verteporfin (Visudyne)FDA Link 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	nasIBA 01/2021
1	sodium-bile acid cotransporterIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	NucleosidesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2019
1	Interleukin-27 (Interleukin 27)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	enhancer-binding protein AP-4IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2016
1	VaccinesIBA 08/2015
1	Prothrombin (Factor II)IBA 01/2015
1	Dinoprostone (PGE2)FDA Link 03/2014
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2013
1	ParaffinIBA 01/2012
1	AlbuminsIBA 09/2011
1	methionylmethylsulfonium chloride (MMSC)IBA 09/2011
1	AgarIBA 06/2011
1	Epidermal Growth Factor (EGF)IBA 04/2009

Therapy/Procedure

3	Therapeutics 10/2022 - 11/2008
2	Plasma Exchange 08/2023 - 01/2022
2	Transplantation 08/2021 - 09/2011
1	Immunotherapy 10/2022
1	Liver Transplantation 04/2022